

Vaccinating India's Kids
While the government is looking at approving Covaxin for those between 2-18, experts advise exercising caution amidst a lack of choices and data for healthy kids before they return to school. Virologist Dr. Gagandeep Kang and Dr. Anand Pillai, Assistant Professor, Global Institute of Public Health, Ananthapuri…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from The Morning Brief
See all episodes →Similar episodes from other shows
More like The Morning Brief →
The Vaccine Scaling Problem

Giving Kids a Shot

New regulations for Ladakh, an alarming study, and India gets G7 invite

Vaccinating children, lockdowns, and ebikes
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.


